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ABSTRACT
Objectives: Endometrial receptivity plays the most important role for successful implantation. Increasing endometrial 
receptivity may improve infertility and increase Assisted Reproductive Technologies success. The aim of this study was to 
investigate the effect of exosome specific markers CD63 and CD9 which are promising molecules in the pathogenesis and 
treatment of many diseases on endometrial receptivity in women with unexplained infertility.
Material and methods: This prospective study was conducted between November 2015 and March 2017. Proliferation 
and secretion periods of endometrial samples from fertile and infertile cases were collected. The paraffin-embedded 
tissue sections were stained with hematoxylin-eosin for the immunohistochemical analysis distributions of CD63 and CD9. 
Results: The results of this study demonstrated that the CD63 immunoreactivity was higher in both luminal and glandular 
epithelium of infertile patients when compared with fertile patients during the proliferative phase (p   =  0.009, p   =  0.008). In 
the infertile proliferation phase, endometrium CD9 immunoreactivity was rarely detected in both the luminal and glandular 
epithelium. In the secretion phase of endometrium, CD9 immunoreactivity was mild in fertile patients, the increased 
immunoreactivity of CD9 was observed in both luminal and glandular epithelium of infertile patients (p   =  0.037, p   =  0.037). 
Conclusions: Increased levels of CD63 in infertile proliferation phase endometrium should represent an unfavorable 
signaling. Moreover, the increased levels of CD9 in infertile secretion phase endometrium could be used as a biomarker 
to evaluate endometrial receptivity. These exosome-specific markers can be considered as potential molecular markers 
of infertility.
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INTRODUCTION
Infertility is a condition that has psychological, economic 
and medical effects which cause trauma and stress especially 
on the people who desire to have children [1]. Infertility 
is a reproductive system disease defined by the inability 
to achieve clinical pregnancy after unprotected sexual 
intercourse for 12 months or more [2, 3]. Unexplained 
infertility is the absence of identifiable causes for infertility [3]. 
Endometrial receptivity plays a critical role for successful 
implantation, and impaired endometrial receptivity may 
lead to subfertility and limit the success of Assisted Repro-
ductive Technologies (ART) [4]. Implantation, a critical step 
in the establishment of pregnancy, ensues under the uterine 
fluid microcirculation signals which contain various proteins, 
lipids and other molecules secreted from the endometrium 
and possibly from the fallopian tubes and blastocyst (such 
as hCG) [5]. Unexplained infertility has been suggested to 
be caused by a disorder in molecular and cellular biomark-
ers in endometrial receptivity [6]. In studies on unexplained 
infertility, which is explained as a high failure of implantation 
after ART, pro-inflammatory factors and interleukins have 
been shown in uterine wall invasion [7]. 
Extracellular vesicles contain exosomes, microvesicles 
and apoptotic bodies and they are also a heterogeneous 
group of particles defined by their size, composition and 
density. The smallest extracellular vesicles are exosomes 
(30–100 nm) released by plasma membrane fusion of 
multivesicular bodies containing intraluminal vesicles [8, 9]. 
Exosomes which are nanoparticles capable of specifi-
cally transferring small RNAs and messenger RNA (mRNAs) 
through the extracellular medium to cells located in distant 
regions can be isolated from culture supernatants of cell 
241
Yıldız Uyar et al., Exosomes on implantation at infertility
www. journals.viamedica.pl/ginekologia_polska
lines or from various body fluids [10]. According to cells, the 
exosomal content may vary. However, different cell-based 
exosomes also express certain common exosome specific 
proteins. Among these proteins are CD9, CD37, CD53, CD63, 
CD81 and CD82 tetraspanin molecules [10]. Exosomes can be 
characterized and purified via their specific cell surface mark-
ers like tetraspanins CD63 and CD9 which are responsible 
for exosome formation. Moreover, exosomes present signal 
transduction (EGFR), antigen presentation (MHC I and MHC II) 
and other transmembrane proteins (LAMP1) on their sur-
face [10, 11]. Exosome secretion has been demonstrated 
in a number of cell types, including embryonic stem cells 
and in vitro produced embryos [12]. Some studies have 
shown that exosomes in the uterine cavity or slightly larger 
microvesicles (100–300 nm) are released from the endome-
trial epithelium. These exosomes or microvesicles contain 
specific miRNAs so that these miRNAs can be transferred 
to the trophectoderm cells or endometrial epithelial cells 
to promote implantation [13, 14].  
Objectives
The aim of this study was to investigate the distribution of 
exosomes in endometrial samples taken during proliferation 
and secretion periods from fertile and unexplained infertile 
patients and their effects on implantation in unexplained 
infertility. 
MATeRIAl AND MeTHODS
Study Design and experimental Groups
The study was conducted using fertile (n = 5 prolifera-
tion phase and n = 5 secretion phase) and infertile (n =  5 
proliferation phase and n = 5 secretion phase) patients who 
were between 25- and 38-years age. Endometrial specimens 
were obtained by probe curettage or by pipelling during 
proliferation and secretion period of the menstrual cycle 
from both fertile and infertile patients. Menstrual cycle 
phase was confirmed by histological dating [15]. Prior to 
commencing with study, ethical permission was taken from 
Health Science Ethics Committee and written informed 
consent was obtained from all participants. 
Selection of Patient Groups
The current study involved female participants aged 
between 25–38 years. Participants were selected from 
amongst patients that were admitted to our hospital 
Obstetrics and Gynecology Clinic. 
Participants in the fertile group had at least one child, 
did not have any uterine disease, had dysfunctional 
uterine bleeding, and had to undergo curettage during 
a non-hemorrhagic period. The infertile group consisted of 
participants who had no children, had been married for at 
least 1 year and were not able to achieve clinical pregnancy 
after unprotected sexual intercourse for 12 months. Infertile 
cases were determined based on clinical diagnosis, 
anamnesis, radiological and ultrasound assessments. 
Either endometrial evaluation for diagnosis or treatment, 
curettage materials from infertile and fertile patients were 
taken under anesthesia via probe curettage or pipelined 
endometrial sampling. Samples were collected from 
patients that were clinically diagnosed as fertile or infertile 
with dysfunctional uterine bleeding. 
In the current study, the menstrual cycle-related intake of 
the samples is essential. Thus, any other organic endometrial 
changes outside the dysfunctional uterine bleeding were 
deactivated and standard sample uptake was achieved. 
Patients with a pathologic diagnosis of an organic cause 
such as hyperplasia, neoplasia or polyps, or an organic lesion 
such as myoma in the examination and who had been using 
steroid hormones for at least six months prior to the study 
were not included in this study.
As a result of endometrial sampling, patients with 
endometrium in the proliferation phase and secretion 
phase were chosen among the patients who admitted 
to our gynecology outpatient clinic with the complaint 
of abnormal bleeding and diagnosed with dysfunctional 
uterine bleeding excluded from organic reasons and whose 
BHCG negative on day of endometrial sampling included 
in our study.
The current study consists of two groups of patients, 
fertile and infertile. The endometrial samples taken from 
both patient groups were divided further into fertile pro-
liferation (Group 1), infertile proliferation (Group 2), fer-
tile secretion (Group 3) and infertile secretion (Group 4) 
groups. 
Histological evaluation
The endometrium tissue samples were fixed in 10% 
neutral formalin and then embedded in paraffin using 
standard protocols. After processing, samples were 
embedded in paraffin and 5 μm sections were taken. Sections 
were used for both histochemical and immunohistochemical 
analyses.
Histochemical Analyses
For morphological evaluation, sections taken from the 
paraffin blocks at 5 μm thickness with a rotary microtome 
were deparaffinized overnight at 60°C (Nuve, FN 400), 
followed by chemical deparaffinization with xylene for 
1 hour. The sections were passed through the decreasing 
alcohol series (95%, 80%, 70% and 60% alcohol series) 
for 2 minutes each and the sections were treated for 
6 minutes with Hematoxylin (Leica, 3801562E) solution. 
Sections were washed for 5 minutes under water and then 
stained with Eosin (Bio-Optica, 380610) for 1.5 minutes after 
242
Ginekologia Polska 2020, vol. 91, no. 5
www. journals.viamedica.pl/ginekologia_polska
differentiating with 1% acid-alcohol solution. Sections were 
taken up into xylene by passing through increasing alcohol 
series (80% and 95%). The sections which were left in xylene 
for 1 hour were covered with cover glasses (Marienfeld, 
01 01060) using entellan solution (Merck, UN 1866) and 
examined under a light microscope (Olympus BX43). 
Immunohistochemical Analyses
For immunohistochemical evaluation of the CD63 and 
CD9, avidin-biotin-peroxidase indirect immunohistochem-
istry method was used. After deparaffinization of sections 
as above, they were washed with phosphate buffered saline 
(PBS) and 3% H2O2 (H1009, Sigma-Aldrich, USA) was ap-
plied. They were then washed with PBS again. For antigen 
retrieval, they were incubated with trypsin for 10 minutes 
in 37°C and then washed with PBS. Sections were then incu-
bated with blocking serum for 1 h and, anti-CD63 (sc-5275, 
lot #D0115, Santa Cruz, USA), and anti-CD9 (sc-13118, lot 
#K1814, Santa Cruz, USA) primer antibodies in a 1/50 dilu-
tion for both antibodies were added and incubated at 4°C 
for overnight. After the washing step with PBS, the second-
ary antibodies biotin (30 min) and streptavidin (30 min) 
were applied respectively (Histostain®-Plus Bulk Kit Cat No: 
85-9043- Invitrogen, Carlsbad, California, United States). 
Immunoreactivity was visualized by the application of 50 µl 
DAB chromogen (Histostain-Plus IHC Kit, DAB, broad spec-
trum Cat No. 859643, Invitrogen, Carlsbad, California, United 
States). After washing with distilled water, they were counter 
stained with Mayer’s hematoxylin and covered with immu-
nohistochemistry mounting medium. Immunohistochemi-
cal process was repeated 3 times. Immunohistochemical 
staining was scored using a semi-quantitative analysis is 
based on the calculation of HSCORE = ∑Pi(i+1) (i = intensity 
of staining and Pi is the percentage of positively stained 
cells for each intensity) formula after evaluation of intensi-
ties as 1 (mild), 2 (moderate) or 3 (strong) [16–19]. For each 
antibody, five different fields were evaluated by at least 
two investigators independently under light microscope 
(BX43, Olympus), blinded to the source of the samples as 
well as to each other’s results and the average score was 
then utilized. Results were given as median after analyz-
ing statistically with Mann-Whitney U test for differences 
among groups. When the p value was < 0.05, the data was 
considered significant.  
ReSUlTS
Histological Results
After hematoxylin and eosin staining, endometrial 
luminal and glandular epithelium were observed in all 
groups. The luminal epithelium was a single-layered co-
lumnar epithelium during proliferation phases of both the 
fertile and infertile patients. The glands in the connective 
tissue of the lamina propria were round in shape and had 
single-layered columnar epithelium in both fertile and 
infertile patients in proliferative phase (Fig. 1A–F). In the 
secretory phase of the fertile and infertile patients’ endome-
trium, the luminal epithelium was a single-layered columnar 
epithelium and the gland structures appeared as glycogen 
vacuoles in the basal parts of the glandular columnar epi-
thelium (Fig. 1G–L).
Immunohistochemical Results
In the proliferative phase of the fertile patients’ endo-
metrium, weak immunoreactivity of CD63 was detected 
in both the luminal (HSCORE = 190) (min–max; 170–200) 
and glandular epithelium (HSCORE = 170) (min–max; 150-
205), and also mild CD63 immunoreactivity was detected 
in the stroma (Fig. 2A, B). In the proliferative phase of the 
infertile patients’ endometrium, increased (mild/strong) 
CD63 immunoreactivity was detected in both the lumi-
nal (HSCORE = 310) (min–max; 300–325) and glandular 
epithelium (HSCORE = 315) (min–max; 310–320) when 
compared to the fertile group, they were statistically sig-
nificant (p = 0.009, p = 0.008) (Tab. 1 and Fig. 3). Intensity 
of CD63 immunoreactivity in stroma was seen similar in 
both fertile and infertile group (Fig. 2C, D). In the secre-
tion phase of the fertile patient’s endometrium, weak and 
mild immunoreactivity of CD63 was detected in the lumi-
nal (HSCORE = 175) (min–max; 165–175) and glandular 
epithelium (HSCORE = 285) (min–max; 255–305) respec-
tively, mild CD63 immunoreactivity was also observed 
in the stroma (Fig. 2E, F). In the secretion phase of the 
Figure 1. Hematoxylin and eosin staining of endometrium. Prolifera-
tive phase of fertile patients (A–C), proliferative phase of infertile pa-
tients (D–F), secretion phase of fertile patients (G–I), secretion phase 
of infertile patients (J–L). (A, G, H, K, L Scale Bars: 20 µm) (B, C, D, E, F, 
I and J Scale Bars: 50 µm)
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infertile patient’s endometrium, increased (mild/moder-
ate) CD63 immunoreactivity was detected in both luminal 
(HSCORE = 200) (min–max; 200–200) and glandular epithe-
lium (HSCORE  = 250) (min–max; 250–250) when compared 
with fertile group, however, this intensity was slightly less 
than the proliferative phase of the infertile endometrium 
(Fig. 2G, H) and when compare the results it was statisti-
cally significant (p = 0.034, p = 0.037) (Tab. 1 and Fig. 3). In 
addition, intensity of CD63 in the stroma of the infertile 
secretion phase of the endometrium (mild) decreased when 
compared with other groups (Fig. 2). 
CD9 immunoreactivity was observed as very weak in 
the infertile proliferation phase of endometrial luminal 
(HSCORE = 130) (min–max; 115–135) and glandular epithe-
lium (HSCORE = 140) (min–max; 100–160) (Fig. 4C, D). This im-
munoreactivity was weaker then fertile proliferation luminal 
epithelium (HSCORE = 150) (min–max; 130–170) (p = 0.025). 
In contrast to that, CD9 immunoreactivity was not observed 
in the fertile proliferation glandular epithelium (Fig. 4A, B). It 
was evident that there were significant differences between 
fertile and infertile proliferation gland epithelium (p = 0.005) 
(Tab. 1 and Fig. 5). In stroma, CD9 immunoreactivity was 
weak in fertile proliferation endometrium, but not observed 
in infertile proliferation tissue samples. In the infertile secre-
tion phase, CD9 immunoreactivity was weak/moderate in 
the luminal (HSCORE = 220) (min–max; 220–220) and the 
glandular epithelium (HSCORE = 220) (min–max; 220-220) 
(Fig. 4G, H), whereas CD9 immunoreactivity of fertile secretion 
luminal (HSCORE = 150) (min–max; 130–170) and glandular 
epithelium (HSCORE = 160) (min–max; 160–170) was weak 
(Fig. 4E, F). It was clearly observed that there were significant 
differences between fertile and infertile secretion phase epi-
theliums (p = 0.037, p = 0.037) (Tab. 1 and Fig. 5). In stroma, 
CD9 immunoreactivity was very weak in the fertile secretion 
tissues, but not observed in infertile secretion tissues.
DISCUSSION
In our study, we showed that there were differences in 
the release of CD63 and CD9 membrane surface proteins 
Figure 2. Immunohistochemical distribution of CD63. Scale Bars: 10 µm
Table 1.  p values of statistical comparisons of CD63 and CD9 HSCORE 
results
CD63
Compared Groups p Value
Fertile proliferation vs infertile proliferation (luminal 
epithelium) p = 0.009
Fertile proliferation vs infertile proliferation (glandular 
epithelium) p = 0.008
Fertile secretion vs infertile secretion
(luminal epithelium) p = 0.034
Fertile secretion vs infertile secretion
(glandular epithelium) p = 0.037
CD9
Compared Groups p Value
Fertile proliferation vs infertile proliferation (luminal 
epithelium) p = 0.025
Fertile proliferation vs infertile proliferation (glandular 
epithelium) p = 0.005
Fertile secretion vs infertile secretion
(luminal epithelium) p = 0.037
Fertile secretion vs infertile secretion
(glandular epithelium) p = 0.037
Figure 3. HSCORE values of CD63 immunoreactivities. FP — Fertile 
Proliferation; IP — Infertile Proliferation; FS — Fertile Secretion; 
IS — Infertile Secretion; LE — Luminal Epithelium; GE — Glandular 
Epithelium
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used to characterize exosomes in luminal and glandular 
epithelium of the endometrium between the unexplained 
infertility and the fertile women. 
To date, many researchers have been stated that it is 
well known the endometrial epithelium is the first maternal 
surface to interact with the implanting embryo. And they 
also stated that the inclusion of extracellular vesicles in 
the implantation process is a relatively new phenomenon 
[14, 20–24]. In many studies; extracellular vesicles containing 
specific RNAs, including microRNAs and proteins, have been 
released into the uterine cavity and transferred to tropho-
blast cells or endometrial epithelial cells where they pro-
mote implantation [13, 14, 21, 25]. Ng YH et al. [14] showed 
for the first time that the tetraspanins, CD9 and CD63 used as 
cell surface markers of exosomes that exist on the surface of 
fertile endometrial epithelial cells and they contain specific 
miRNAs in the endometrial epithelium and stated that the 
exosomes and/or exosome-derived miRNA could be used 
as biomarkers for endometrial receptivity.
Our results demonstrated that CD63 expression in the 
secretion phase endometrium of fertile group was higher 
in the glandular epithelium compared to the luminal 
epithelium, and this intensity was statistically significant. 
It was observed that intensity of CD63 in luminal and 
glandular epithelial in the infertile proliferation phase 
group was higher when compared to the fertile proliferation 
phase group, and also this increased immunoreactivity was 
statistically significant. However, significantly decreased 
CD63 expression was detected during infertile secretion 
phase compared to the infertile proliferation phase. 
Ng YH et al. [14]; in their study, showed that CD63 and 
CD9 had strong apical staining in the luminal and glandular 
epithelial cells of fertile women, and interestingly, this stain-
ing for CD63 reached the highest levels in the mid-secretory 
period, which is the time of endometrial receptivity and 
they said it might be important in implantation. Therefore, 
they stated that enough secretion of increased exosome 
production in the mid-secretory period was needed for the 
implantation window and if this process could not proceed 
properly, result with implantation failure. As a result, Ng YH 
et al. [14]; have expressed that exosomes modulate the be-
havior of the immune system and cancer cells and because 
the embryo implantation is in common with the behavior 
of immune system and cancer cells, the clarification of the 
function of the exosomes in the uterine cavity will extend 
our understanding of the endometrial-embryo cross talk 
and infertility. 
In our study, we found that CD63 expression was 
similar and weak in the glandular and luminal epithelium 
of the fertile proliferative phase endometrium’s, whereas 
CD63 expression in the glandular epithelium in the fertile 
secretion phase increased significantly. It is thought that 
during implantation, CD63 has an especially increased in 
glandular epithelium, and the luminal secretion of CD63 is 
similar in the proliferation and secretion phases of fertile 
group, so that CD63 secreted from the glandular epithelium 
may have a controlling role in implantation.
According to the results of our study, CD63 could not 
be accepted as an indicator or biomarker of endometrial 
signaling pathways in the infertile group due to the 
CD63 expression levels in the infertile group during the 
proliferation phase, furthermore the CD63 secretion was 
slightly increased in luminal epithelium but decreased 
Figure 4. Immunohistochemical distribution of CD9. Scale Bars: 10 µm
Figure 5. HSCORE values of CD9 immunoreactivities. FP — Fertile 
Proliferation; IP — Infertile Proliferation; FS — Fertile Secretion; 
IS — Infertile Secretion; LE — Luminal Epithelium; GE — Glandular 
Epithelium
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in glandular epithelium in the infertile secretion phase 
compared to the fertile secretion phase. However, the 
observed increase of proliferation phase CD63 in the infertile 
group compared to the fertile group suggests that exosomal 
trafficking increases in the endometrial epithelium and it 
may cause negative effects in order to control different 
signal pathways before implantation. 
Burnett LA et al. [26] stated in their review that several 
studies have demonstrated that interactions between the 
embryo and the uterine microenvironment are important 
for successful implantation and healthy pregnancy [12, 14, 
27, 28]. In their studies, Rosenbluth EM et al. [12], have 
shown that some exosomal miRNAs can be secreted by hu-
man embryos in IVF cycles and that these exosome-derived 
miRNAs can be secreted into the IVF culture environment 
that can be used as a biomarker in predicting IVF success 
and outcome of pregnancy. 
Our study showed that CD9 immunoreactivity in the 
glandular epithelium in the fertile proliferation phase was 
significantly different compared to the luminal epithelium. 
Thus, CD9 expression was thought to be secreted mainly in 
the luminal epithelium of fertile proliferative phase. Howev-
er, in the luminal epithelium of infertile proliferative phase, 
the CD9 immunoreactivity decreased and it was statistically 
significant compared to the fertile group. In the infertile 
proliferative phase, CD9 immunoreactivity was significantly 
expressed in the glandular epithelium. 
It was clearly seen that the CD9 expression in the 
glandular epithelium of fertile secretion group increased 
compared to the fertile proliferation phase significantly, 
however the increase of CD9 immunoreactivity in the infertile 
secretion phase compared to both fertile groups and infertile 
proliferation phase group is higher. CD9 immunoreactivity 
was increased in the infertile secretion phase compared to 
the fertile secretion phase and this increase was statistically 
significant. The distribution of CD9 in both luminal and 
glandular epithelium of infertile secretion phase was also 
found to be higher than the infertile proliferation phase and 
it was statistically significant. 
Expression of CD9 in the fertile secretion phase supports 
the presence of exosomes for endometrial regulation before 
implantation in both luminal and glandular epithelium. In 
contrast, in the infertile secretion phase, the CD9 increase 
in both luminal and glandular epithelium significantly 
increased, suggesting that the exosomal traffics were 
greater in both epithelium of infertile endometrium may 
be cause of unexplained infertility.
Iwai et al. [29] showed that changes in CD9 localization 
due to cellular activity in mice and human uterine secretions 
and stated that these changes may be related to infertility. 
Chaudhari-Kank MS et al. [30] showed that expression of 
CD9 had decreased in endometrial stromal cells of infertile 
women. They also stated that this decrease in CD9 expression 
could cause to infertility by impairing implantation. In the 
study of Chaudhari-Kank MS et al. [30], all cases were only in 
the secretory period. In our study, proliferation and secretion 
periods of infertile cases were evaluated and CD9 in stroma, 
on this subject in both phases expression was observed 
similar to the results of Chaudhari-Kank MS et al. study which 
is one of the most recent studies.
According to our study’s results, we haven’t thought that 
CD63 could be used as a biomarker in infertility. However, 
due to the significant increase of CD9 in the secretory 
phase of infertile group, it may be possible to use CD9 to 
assess infertility related issues or as a biomarker in terms 
of endometrium.
CONClUSIONS
Based on the findings of this study increased 
CD9 reactivity in infertile secretion phase endometrium 
could be used as a biomarker which could be an unfavorable 
signaling of infertility or increased expression for recovery. 
In addition the increase of CD63 in the infertile proliferation 
group suggested that exosomal expression in the endomet-
rial epithelium before implantation was changed and may 
have negative effects.
It can be stated that endometrial differences of exosomes 
may affect implantation and the results of our study may 
shed light on future studies. To predict the use of exosomes 
in infertility, particularly CD9 as a biomarker, further studies 
are needed to be done.
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